Quote:
Originally Posted by JD159
I think they mention something about companies who would want to create generic versions can't get their hands on enough samples due to regulation.
|
I saw that, but I don't buy it. Any drug whose patent is long expired and can sustain a 5000% price hike would definitely be worth buying up whatever number of samples required to copy it. Whatever it costs, it would be worth it, especially given the bad
PR Shkreli is going to suffer .... because of his d'bag-like appearance and, more importantly, all the people who think drug prices should be
inversely proportional to their market demand - the opposite of how everything in capitalism actually works.